The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma.Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive powerlift ...

The FreeStyle Libre 3 system helped Nathan manage his diabetes. Now, he's sharing his story to help lift stigma. Abbott NORTHAMPTON, MA / ACCESS Newswire / February 7, 2025 / As a competitive ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The company is taking the plunge into an insulin pump and continuous glucose monitor global market that is forecast ... In a move to improve access, Beta Bionics integrated iLet with Abbott’s ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Abbott Laboratories is a well-diversified health care company, with four distinct units: medical devices, diagnostics, nutrition and ...

Abbott sells market-leading products across its businesses, from the Ensure brand in its nutrition business to the FreeStyle Libre continuous glucose monitoring (CGM) system in its medical devices ...

Abbott’s FreeStyle Libre CGM system has been a big growth driver. Now, the company adds to its CGM portfolio with the launch of Lingo, the first available without a prescription. Tee up Don’t ...

For the full calendar of 2024, Abbott recorded sales of $41.95 billion, following the launches last year of a new heart valve repair implant and FDA clearances for two over-the-counter blood sugar ...

The FreeStyle Libre 3 reader with the sensor ... from recently launched products such as OTC CGM Lingo targeting adults without diabetes,” the analysts wrote. The over-the-counter (OTC) Lingo system ...